Vernalis Plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vernalis Plc with three other
companies in this sector in the United Kingdom:
Redx Pharma PLC
sales of £30.47 million [US$42.56 million]
(£7.25 million [US$10.12 million]
(£5.79 million [US$8.08 million]
of which 45%
was Diagnostics Segment).